- Home
- HCC vs PRCT Comparison
HCC vs PRCT Comparison
Compare HCC & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCC
- PRCT
- Stock Information
- Founded
- HCC 2015
- PRCT 2009
- Country
- HCC United States
- PRCT United States
- Employees
- HCC N/A
- PRCT N/A
- Industry
- HCC Coal Mining
- PRCT Medical Specialities
- Sector
- HCC Energy
- PRCT Health Care
- Exchange
- HCC Nasdaq
- PRCT Nasdaq
- Market Cap
- HCC 2.5B
- PRCT 2.9B
- IPO Year
- HCC 2017
- PRCT 2021
- Fundamental
- Price
- HCC $45.30
- PRCT $53.12
- Analyst Decision
- HCC Strong Buy
- PRCT Strong Buy
- Analyst Count
- HCC 5
- PRCT 7
- Target Price
- HCC $70.25
- PRCT $90.00
- AVG Volume (30 Days)
- HCC 853.0K
- PRCT 1.1M
- Earning Date
- HCC 04-30-2025
- PRCT 04-24-2025
- Dividend Yield
- HCC 0.71%
- PRCT N/A
- EPS Growth
- HCC N/A
- PRCT N/A
- EPS
- HCC 2.01
- PRCT N/A
- Revenue
- HCC $1,319,451,000.00
- PRCT $249,121,000.00
- Revenue This Year
- HCC N/A
- PRCT $46.28
- Revenue Next Year
- HCC $26.14
- PRCT $32.67
- P/E Ratio
- HCC $22.48
- PRCT N/A
- Revenue Growth
- HCC N/A
- PRCT 59.36
- 52 Week Low
- HCC $38.00
- PRCT $47.04
- 52 Week High
- HCC $75.53
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- HCC 42.79
- PRCT 46.17
- Support Level
- HCC $43.43
- PRCT $52.43
- Resistance Level
- HCC $47.79
- PRCT $56.29
- Average True Range (ATR)
- HCC 2.00
- PRCT 2.88
- MACD
- HCC -0.28
- PRCT 0.28
- Stochastic Oscillator
- HCC 26.52
- PRCT 48.53
About HCC Warrior Met Coal Inc.
Warrior Met Coal Inc is a U.S based company. It produces and exports of met coal that operates underground mines in Alabama. The company sells to steels manufacturers in Europe, Asia, and South America. Its mining operations consist of two underground met coal mines in Southern Appalachia's coal seam and other surface met and thermal coal mines. The Company generates ancillary revenues from the sale of natural gas extracted as a byproduct from the underground coal mines and royalty revenues from leased properties.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.